Great West Life Assurance CO Rhythm Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $63.1 Billion
- Q2 2025
A detailed history of Great West Life Assurance CO transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 11,578 shares of RYTM stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,578
Previous 11,578
-0.0%
Holding current value
$1.32 Million
Previous $615,000
19.19%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RYTM
# of Institutions
254Shares Held
64.3MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$767 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$638 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$633 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$555 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$408 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $6.34B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...